James Paul Scopa Insider Trading $ADVM Adverum Biotechnologies, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Paul Scopa.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Paul Scopa. James Paul Scopa is Director in Conatus Pharmaceuticals Inc. ($CNAT) and in TriVascular Technologies, Inc. ($TRIV) and Director in TriVascular Technologies, Inc. ($TRIV) and Director in Adverum Biotechnologies, Inc. ($ADVM) and Director in Aligos Therapeutics, Inc. ($ALGS).
James Paul Scopa in Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James Paul Scopa: Director
Holdings: 53,334 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James Paul Scopa in Adverum Biotechnologies, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, ALGS, HSTO, TRIV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| May 05 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | M | 6.48 | 23,334 | 151,204 | 46,666 | |
| May 05 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Buy | M | 6.48 | 23,334 | 151,204 | 53,334 | 30 K to 53.3 K (+77.78 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Buy | P | 13.75 | 10,000 | 137,500 | 30,000 | 20 K to 30 K (+50.00 %) |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 13.41 | 11,250 | 150,863 | 11,250 | |
| May 06 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Buy | P | 6.71 | 20,000 | 134,200 | 20,000 | 0 to 20 K |
| May 03 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 6.48 | 70,000 | 453,600 | 70,000 |
Page: 1